Autopsy report · NCT05796167
Pimavanserin for Sleep in Parkinson Disease
Cause of deathStaffing, sites or logistics
“The PI did not have eligible candidates. Therefore, Acadia Pharmaceuticals (the sponsor) closed the study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- State University of New York - Downstate Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Parkinson Disease
- Interventions
- Pimavanserin
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling
“Delivery of equipment. PI not had any further interaction with the company so closed study.” - Maternal Epidural Steroids and Hyperthemia
“PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study is closed” - Changes in Bone Turnover With Increased Incretin Hormone Exposure
“Study closed by sponsor. Funding ended.” - Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing
“The PI closed this study and went to another institution.” - Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
“The study was closed due to the end of funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.